Mar 16, 2022 08:33AM
Mar 16, 2022 08:30AM
Mar 16, 2022 08:30AM
Feb 28, 2022 09:00AM
Jan 21, 2022 11:04AM
Jan 21, 2022 11:04AM
Nov 10, 2021 07:30AM Kaleido Biosciences Inc. (KLDO) to Appoint Dr. Alison Long as Chief Medical Officer
Nov 10, 2021 07:30AM
Nov 10, 2021 07:30AM
Nov 1, 2021 07:30AM
Nov 1, 2021 07:30AM
Oct 5, 2021 07:02AM
Oct 5, 2021 07:00AM
Oct 5, 2021 07:00AM Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative Colitis
Sep 29, 2021 07:30AM
Sep 29, 2021 07:30AM
Sep 7, 2021 07:54AM
Sep 1, 2021 01:44PM
May 4, 2021 07:30AM
May 4, 2021 07:30AM
Mar 24, 2021 07:07AM Kaleido Biosciences (KLDO) Reports Positive Results from Non-IND Study Demonstrating Reduction in COVID-19 Related Healthcare Utilization and Recovery Time in Patients with Mild-to-Moderate COVID-19 a
Mar 24, 2021 07:00AM
Mar 24, 2021 07:00AM
Jan 11, 2021 08:15AM
Jan 11, 2021 08:00AM
Jan 5, 2021 07:30AM
Jan 5, 2021 07:30AM
Dec 12, 2019 08:08AM Kaleido Biosciences Inc. (KLDO) to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis
Dec 12, 2019 08:00AM
Dec 12, 2019 08:00AM
Nov 19, 2019 04:30PM
Nov 8, 2019 07:00AM
Oct 2, 2019 07:00AM
Apr 12, 2019 07:32AM
Apr 12, 2019 07:30AM Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress�
Apr 12, 2019 07:30AM
Mar 27, 2019 08:16AM
Mar 27, 2019 08:15AM
Mar 27, 2019 08:15AM
Mar 8, 2019 08:30AM
Mar 8, 2019 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All